Dr. Steven E. Nissen of Cleveland Clinic discusses the results of a post hoc analysis of data from the STRENGTH trial with Dr. Ron Waksman. The analysis, presented as a late-breaking trial at ACC.21 Virtual, showed no association of benefit or harm with the use of high-dose omega-3 fatty acids in patients at high cardiovascular risk.